|
Resolution: standard / high Figure 2.
Cardiovascular risk in patients with arthritis: celecoxib versus NSAIDs, naproxen,
or placebo. Shown is a summary of the risk for death, myocardial infarction, and stroke
for celecoxib relative to nonsteroidal anti-inflammatory drugs (NSAIDs), naproxen,
or placebo in patients with arthritis [30]. *P = nonsignificant. Reproduced with permission from Elsevier [30].
Borer and Simon Arthritis Research & Therapy 2005 7(Suppl 4):S14 doi:10.1186/ar1794 |
